The Home of Specialty Pharmaceuticals & Generics

Thornton and Ross are committed to providing cost-effective treatment for the NHS and pharmacies in the UK. As part of the STADA Group, Thornton and Ross are constantly adding to their existing product portfolio and continue to be seen as global leaders of specialty, biosimilar and generic products.

Lets stay connected!

Want to be the first to hear about the products, services and educational resources we offer, including invitations to webinars and events?

Sign Up Here

Specialty & Biosimilars

At Thornton & Ross, we continue to offer expertise and outstanding value in Specialty Pharmaceuticals that treat a wide range of conditions and diseases.

Visit Our Website

Uzpruvo is STADA’s ustekinumab biosimilar and offers a cost-effective alternative to the reference product.^1,2

Uzpruvo (ustekinumab) is indicated for the treatment of moderate to severe Crohn’s disease in adults, moderate to severe plaque psoriasis in adults, moderate to severe paediatric plaque psoriasis and psoriatic arthritis in adults.¹

Uzpruvo is currently not approved for the Ulcerative Colitis indication (since the originator still has exclusivity for this indication).

Prescribing Information can be found here

1. Uzpruvo SmPC. Last accessed: July 2024.
2. Cost of Uzpruvo and reference product (Stelara) taken from NHS DM+D. Last accessed: July 2024.

Visit Our Website

Kinpeygo^® - the first and only disease-modifying treatment approved across Europe and by NICE specifically for use in IgA nephropathy.^1,2

Kinpeygo® is indicated for the treatment of primary immunoglobulin A (IgA) nephropathy (IgAN) in adults at risk of rapid disease progression with urine protein-to-creatinine ratio (UPCR) ≥ 1.5g/gram.

Prescribing Information can be found here

1. European public assessment report (EPAR) Kinpeygo. EMA/570757/2022, last revised 05/2022. 2. Overview | Targeted-release budesonide for treating primary IgA nephropathy | Guidance | NICE. https://www.nice.org.uk/guidance/ta937 (Published: 20 December 2023).

Visit Our Website

Our first ophthalmology biosimilar, ranibizumab is a biological medicine that is injected into the eye. Ximluci® is the ranibizumab biosimilar from STADA Thornton and Ross.¹

XIMLUCI®▼ is indicated for adult patients, treatment of: neovascular (wet) age-related macular degeneration (AMD); visual impairment due to diabetic macular oedema (DME); proliferative diabetic retinopathy (PDR); visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO); visual impairment due to choroidal neovascularisation (CNV).

Prescribing Information can be found here

1. XIMLUCI® (ranibizumab) Summary of Product Characteristics. January 2023.
Available at: https://www.medicines.org.uk/emc/product/14461/smpc. Accessed July 2023.

Visit Our Website

Movymia® the teriparatide biosimilar from Thornton & Ross, STADA.

Movymia®▼ is indicated for adults for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture.

Prescribing Information can be found here

Visit Our Website

Generics

Generic medicines in the UK comply with the same standards of quality, safety and efficacy as all medicinal products. Generics are high-quality medicines that offer substantial savings to the NHS. As part of the STADA Group our range of generic medicines is constantly evolving and we are always innovating in this area.

Products
Generics
	Link to Summary of Product Characteristics*
Abiraterone 500mg film-coated tablets	http://www.medicines.org.uk/emc/medicine/42379
Acitretin 10mg Capsules	http://www.medicines.org.uk/emc/medicine/28610
Acitretin 25mg Capsules	http://www.medicines.org.uk/emc/medicine/28609
Apixaban 2.5mg film-coated tablets	https://www.medicines.org.uk/emc/product/14534/smpc
Apixaban 5mg film-coated tablets	https://www.medicines.org.uk/emc/product/14535/smpc
Aripiprazole 1 mg/ml Oral Solution	http://www.medicines.org.uk/emc/medicine/36937
Aripiprazole 10 mg Orodispersible Tablets	http://www.medicines.org.uk/emc/medicine/37551
Aripiprazole 15 mg Orodispersible Tablets	http://www.medicines.org.uk/emc/medicine/37560
Arsenic Trioxide 1 mg/ml concentrate for solution for infusion	http://www.medicines.org.uk/emc/medicine/38677
Atomoxetine 10 mg Hard Capsules	http://www.medicines.org.uk/emc/medicine/37553
Atomoxetine 100 mg Hard Capsules	http://www.medicines.org.uk/emc/medicine/37559
Atomoxetine 18 mg Hard Capsules	http://www.medicines.org.uk/emc/medicine/37554
Atomoxetine 25 mg Hard Capsules	http://www.medicines.org.uk/emc/medicine/37555
Atomoxetine 40 mg Hard Capsules	http://www.medicines.org.uk/emc/medicine/37556
Atomoxetine 60 mg Hard Capsules	http://www.medicines.org.uk/emc/medicine/37557
Atomoxetine 80 mg Hard Capsules	http://www.medicines.org.uk/emc/medicine/37558
Benzylpenicillin sodium 1200mg Powder for Injection	http://www.medicines.org.uk/emc/medicine/32345
Benzylpenicillin sodium 600mg Powder for Injection	http://www.medicines.org.uk/emc/medicine/2962
Bortezomib 2.5mg/ml Solution for Injection (3.5mg total content)	http://www.medicines.org.uk/emc/medicine/36361
Brinzolamide/Timolol 10 mg/ml + 5 mg/ml Eye Drops, suspension	http://www.medicines.org.uk/emc/medicine/39780
Ethambutol 100mg Tablets	http://www.medicines.org.uk/emc/medicine/28701
Ethambutol 400mg Tablets	http://www.medicines.org.uk/emc/medicine/28702
Febuxostat 120 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/38845
Febuxostat 80 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/37552
Fenofibrate 160mg Tablets	http://www.medicines.org.uk/emc/medicine/28612
Fluconazole 50mg/5ml Powder for Oral Suspension	http://www.medicines.org.uk/emc/medicine/28613
Fulvestrant 250 mg solution for injection in pre-filled syringe	http://www.medicines.org.uk/emc/medicine/39429
Gefitinib 250 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/37584
Lenalidomide 10 mg Hard capsules	http://www.medicines.org.uk/emc/medicine/41956
Lenalidomide 15 mg Hard capsules	http://www.medicines.org.uk/emc/medicine/41958
Lenalidomide 2.5 mg Hard capsules	http://www.medicines.org.uk/emc/medicine/41949
Lenalidomide 20 mg Hard capsules	http://www.medicines.org.uk/emc/medicine/41953
Lenalidomide 25 mg Hard capsules	http://www.medicines.org.uk/emc/medicine/41957
Lenalidomide 5 mg Hard capsules	http://www.medicines.org.uk/emc/medicine/41948
Lenalidomide 7.5 mg Hard capsules	http://www.medicines.org.uk/emc/medicine/41945
Linezolid 600mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/36409
Lorazepam 1mg Tablets	http://www.medicines.org.uk/emc/medicine/26011
Lorazepam 2.5mg Tablets	http://www.medicines.org.uk/emc/medicine/26012
Lormetazepam Tablets 0.5 mg	http://www.medicines.org.uk/emc/medicine/28614
Lormetazepam Tablets 1mg	http://www.medicines.org.uk/emc/medicine/28615
Memantine Hydrochloride 10mg/ml Oral Solution	http://www.medicines.org.uk/emc/medicine/34319
Methadone 1mg/ml Oral Solution BP - Sugar Free	http://www.medicines.org.uk/emc/medicine/25339
Methadone Mixture 1mg/ml	http://www.medicines.org.uk/emc/medicine/25342
Naproxen 50mg/mL Oral Suspension	http://www.medicines.org.uk/emc/medicine/37529
Olmesartan 10 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/37561
Olmesartan 20 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/37562
Olmesartan 40 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/37563
Olmesartan/Hydrochlorothiazide 20 mg/12.5 mg film-coated tablets	http://www.medicines.org.uk/emc/medicine/42028
Olmesartan/Hydrochlorothiazide 20 mg/25 mg film-coated tablets	http://www.medicines.org.uk/emc/medicine/42029
Olmesartan/Hydrochlorothiazide 40 mg/12.5 mg film-coated tablets	http://www.medicines.org.uk/emc/medicine/42030
Olmesartan/Hydrochlorothiazide 40 mg/25 mg film-coated tablets	http://www.medicines.org.uk/emc/medicine/42031
Oxazepam Tablets 10mg	http://www.medicines.org.uk/emc/medicine/28750
Oxazepam Tablets 15mg	http://www.medicines.org.uk/emc/medicine/28706
Pemetrexed 25 mg/ml concentrate for solution for infusion	http://www.medicines.org.uk/emc/medicine/39930
Posaconazole 40 mg/ml Oral Suspension	http://www.medicines.org.uk/emc/medicine/37564
Posaconazole STADA 100 mg Gastro-resistant tablets	http://www.medicines.org.uk/emc/medicine/38814
Prasugrel 10mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/36133
Prasugrel 5mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/36132
Pregabalin Genus 20 mg/ml Oral Solution	http://www.medicines.org.uk/emc/medicine/36940
Prucalopride STADA 1 mg, film-coated tablets	http://www.medicines.org.uk/emc/medicine/43114
Prucalopride STADA 2 mg, film-coated tablets	http://www.medicines.org.uk/emc/medicine/43113
Sitagliptin 100 mg Film-coated Tablets	http://www.medicines.org.uk/emc/medicine/42425
Sitagliptin 25 mg Film-coated Tablets	http://www.medicines.org.uk/emc/medicine/42423
Sitagliptin 50 mg Film-coated Tablets	http://www.medicines.org.uk/emc/medicine/42424
Solifenacin 10 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/37583
Solifenacin 5 mg Film-Coated Tablets	http://www.medicines.org.uk/emc/medicine/37582
Trihexyphenidyl 2mg Tablets	http://www.medicines.org.uk/emc/medicine/28617
Trihexyphenidyl 5mg Tablets	http://www.medicines.org.uk/emc/medicine/28618
Zolmitriptan 5mg Orodispersible Tablets	http://www.medicines.org.uk/emc/medicine/36900

Specialty & Biosimilars
	Link to Summary of Product Characteristics*
KINPEYGO▼ (Modified-Release Hard Capsules Budesonide) 4 mg modified-release hard capsules	https://www.medicines.org.uk/emc/product/15393
MOVYMIA▼ (Teriparatide) 20 micrograms/80 microliters solution for injection	http://www.medicines.org.uk/emc/medicine/37009
OYAVAS▼ (Bevacizumab) 25 mg/mL concentrate for solution for infusion	http://www.medicines.org.uk/emc/medicine/40539
UZPRUVO▼ (ustekinumab) 45 mg or 90 mg solution for injection in pre-filled syringe	https://www.medicines.org.uk/emc/product/15826/ https://www.medicines.org.uk/emc/product/15827/
XIMLUCI▼ (Ranibizumab) 10 mg/mL solution for injection	http://www.medicines.org.uk/emc/medicine/42765

Information

* For SmPC follow the links which will take you to the Electronic Medicines Compendium (emc) website which is a non-Thornton & Ross website. https://www.medicines.org.uk/emc/.

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Thornton and Ross Limited by emailing thorntonross@medinformation.co.uk or by calling 01484 848164.

UK-MULT-113(4) | Date of Preparation: July 2024